Jun 28, 2018
CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease
Mar 29, 2018
Behavioral Disorders Drug Development Pipeline Review 2017 - Key Players Involved in Therapeutic Development for Autism, OCD and ADHD
Mar 26, 2018
New Study finds younger aged children with symptoms of ADHD have reduced brain size
Mar 19, 2018
Moderate-Severe Brain Trauma in Children Linked to Increased Risk for ADHD
Feb 28, 2018
CCHR Says Suspected Florida School Shooter Should Not Have Been in Reserve Officer Training if Taking Mind-Altering Stimulants
Feb 07, 2018
Growing with the flow
Feb 01, 2018
New Treatment Option for Adults With ADHD: FOQUEST® (Methylphenidate Controlled Release Capsules) Now Available in Canada
Nov 16, 2017
Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017
Oct 31, 2017
NLS Pharma Announces Poster Presentation On Efficacy and Safety Data of a Controlled Release (CR) Formulation of Mazindol in Adults with ADHD at AACAP's & APSARD's Annual Meeting in the US
Oct 03, 2017
Ehave Highlights Solutions to Support and Improve ADHD Treatment During ADHD Awareness Month
Sep 18, 2017
NeuroPlus Brain-Training Video Games Help Students With ADHD, According to Study By Duke University Researcher
Aug 08, 2017
ORADUR®-Methylphenidate ER Capsule Achieves Primary Endpoint in Phase 3 Study in ADHD in Taiwan
Jun 20, 2017
Shire plc: U.S. FDA Approves Mydayis[TM] (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
Jun 19, 2017
Ehave Launches Conners® Suite of ADHD Assessment Tools for Ehave Connect
Jun 15, 2017
Cingulate Therapeutics Announces Expansion to Accommodate Growth
Jun 05, 2017
Genomind's Industry Accolades Expand, Bolstered By A Strong Scientific Advisory Board
May 31, 2017
NLS Pharma Unveils Positive Phase 2 Data For NLS-1 (mazindol CR) In Adults With ADHD, Demonstrating Significant Improvement In Symptoms
May 26, 2017
NLS Pharma Announces New Information In Support Of The Mechanism Of Action Of Its Lead Compound NLS-1 mazindol CR